Skip to content
Search

Latest Stories

Michael Tibbs becomes one of the first to get Covid booster jab

After making history as the oldest person to receive the Pfizer jab in the UK on December 8, 2020, Michael Tibbs got his booster shot this week in Sussex.

Tibbs received Covid booster vaccination at Midhurst Pharmacy ahead of his 100th birthday in November.


The 99-year-old Second World War submarine lieutenant had received his first jab at Portsmouth's Queen Alexandra Hospital.

Tibbs said: “I’m grateful to receive the booster vaccination as I was to receive the first. I didn’t notice any side effects. Just a prick, and it’s done!

“It’s wonderful and I think it’ll make a lot of difference to everybody.”

Since his vaccinations, Tibbs has taken advantage of his freedom, and is now looking forward to celebrating his 100th birthday with his five great-grandchildren.

The vaccination service at Midhurst Pharmacy is one of more than 30 across Sussex which are now giving covid booster jabs to eligible patients.

Lead pharmacist Raj Rohilla and his team at the pharmacy have been working hard to vaccinate thousands of people in the West Sussex community since the programme began in December last year.

Rohilla said: “It was a real pleasure and an honour to meet Mr Tibbs at our pharmacy. We feel it a real privilege to complete Mr Tibbs' vaccination journey with his Covid booster.

“We would like to urge everyone who is invited for their Covid booster to take up the offer and book with the National Booking System either online or by phoning 119.

“We will also be running regular Drop-in clinics as well.  Please ensure that six months have elapsed between your second Covid vaccination and the booster.

The NHS in Sussex has urged everyone who is invited to follow in the footsteps of people like Tibbs by taking up the offer when they are invited.

People do not need to contact the NHS for vaccination, and will be invited when it is their turn.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less